We are live on ! Find out more
HUMA icon

Humacyte
HUMA

123 hedge funds and large institutions have $150M invested in Humacyte in 2024 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 14

171% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 17

107% more capital invested

Capital invested by funds: $72.4M → $150M (+$77.4M)

28% more funds holding

Funds holding: 96 → 123 (+27)

6.3% more ownership

Funds ownership: 19.91% → 26.2% (+6.3%)

8% less call options, than puts

Call options by funds: $3.34M | Put options by funds: $3.61M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
123
Holders Change
+27
Holders Change %
+28.13%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
46
Increased
51
Reduced
14
Closed
17
Calls
$3.34M
Puts
$3.61M
Net Calls
-$272K
Net Calls Change
+$483K

Top Buyers

1
BlackRock
BlackRock
New York
+$12.2M
2
State Street
State Street
Massachusetts
+$8.62M
3
Millennium Management
Millennium Management
New York
+$6.95M
4
N
Nuveen
North Carolina
+$6.05M
5
Two Sigma Investments
Two Sigma Investments
New York
+$5.81M

Top Sellers

1
ACM
AIGH Capital Management
Maryland
-$6.71M
2
SCM
Sio Capital Management
New York
-$6.22M
3
MIM
Monashee Investment Management
Massachusetts
-$3.75M
4
PGP
Prescott General Partners
Florida
-$1.77M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
PGP
126
Prescott General Partners
Florida
– -$1.77M -568,246 Closed
Capstone Investment Advisors
127
Capstone Investment Advisors
New York
– -$972K -312,400 Closed
LPC
128
Lion Point Capital
New York
– -$731K -235,000 Closed
DCM
129
DG Capital Management
New York
– -$716K -230,238 Closed
CCP
130
Clough Capital Partners
Massachusetts
– -$486K -156,263 Closed
SC
131
Shay Capital
New York
– -$186K -59,858 Closed
SGM
132
Seven Grand Managers
New York
– -$156K -50,000 Closed
AIG
133
American International Group
New York
– -$93.9K -30,180 Closed
HIC
134
Hartline Investment Corp
Illinois
– -$69.8K -22,450 Closed
OAM
135
Oxford Asset Management
United Kingdom
– -$63.4K -20,374 Closed
State of Wisconsin Investment Board
136
State of Wisconsin Investment Board
Wisconsin
– -$51.9K -16,700 Closed
WAM
137
Wolverine Asset Management
Illinois
– -$5.33K -1,715 Closed
MLICM
138
Metropolitan Life Insurance Company (MetLife)
New York
– -$4.61K -1,483 Closed
Comerica Bank
139
Comerica Bank
Texas
– -$3.27K -1,051 Closed
FCAS
140
First Command Advisory Services
Texas
– -$467 -150 Closed
2 3 4 5
6

HUMA Hedge Fund Activity: Q2 2024 in Review

123 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q2 2024, worth a combined $150M — up 107% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new HUMA positions and 17 closed out — a net gain of 29 holders — while 51 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $6.71M sold.

  • 123 institutional investors held Humacyte (HUMA) as of Q2 2024, up from 96 in Q1 2024.
  • Funds reported $150M of Humacyte stock for Q2 2024, up 107% quarter-over-quarter.
  • 46 funds opened new Humacyte positions in Q2 2024 and 17 closed out, a net change of +29 holders.
  • The largest Humacyte buyer in Q2 2024 was BlackRock, an estimated $12.2M added.
  • The largest Humacyte seller in Q2 2024 was AIGH Capital Management, an estimated $6.71M sold.

Based on aggregated 13F filings for Q2 2024.